• R M Walsh, J R Aguilar Saavedra, G Lentz, A D Guerron, J Scheman, T Stevens, M Trucco, R Bottino, and B Hatipoglu.
• Department of General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH, USA. walshm@ccf.org
• J. Gastrointest. Surg. 2012 Aug 1; 16 (8): 1469-77.

BackgroundTotal pancreatectomy (TP) with auto-islet transplant (AIT) is an extreme treatment for chronic pancreatitis, and we reviewed our experience to assess the impact on quality of life (QOL).MethodsA prospective cohort study from 2007 through 2010 with pre- and postoperative assessments of the Depression Anxiety Stress Scale, Pain Disability Index, and visual analogue pain scale was performed.ResultsTwenty patients underwent TP-AIT with a median follow-up of 12 months (6.75-24 months). All patients reported moderate (45 %) to severe (55 %) pain prior to surgery. TP-AIT resulted in significant decreases in abdominal pain (p < 0.001), 80 % reporting no or mild pain. Despite pain improvement, only 30 % discontinued narcotics. Improvements in all PDI QOL domains improved from 79 to 90 % (p = 0.002), with greatest improvements seen in those without prior pancreatic surgery, younger patients, and in those with higher levels of preoperative pain. Patients were less affected by depression and anxiety prior to surgery, but 60 and 70 % did show improvement in depression and anxiety, respectively (p = 0.033). Sixteen patients (80 %) required exogenous insulin at last follow-up (mean total dose of insulin 11.6 U/day).ConclusionsTP-AIT significantly improves pain and QOL measures in appropriately selected patients with CP.

40 keywords...

hide…